Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood +7 more
wiley +1 more source
Multivalent amphiphilic cyclodextrins for selective membrane disruption with potent antifungal activity. [PDF]
Miyagawa A +9 more
europepmc +1 more source
Exploring DHPM-azole hybrid molecules for antibacterial drug discovery: synthesis and biological assessment. [PDF]
Kumar G +7 more
europepmc +1 more source
Novel diazene-tri(phenoxy-1,2,3-triazole-acetamide) derivatives as potent α-glucosidase inhibitors: synthesis, biological evaluation, and <i>in silico</i> studies. [PDF]
Kermaninia S +11 more
europepmc +1 more source
Combining Triazole Scaffold Repurposing and Generative Transformer Architecture for Structure-Based Inhibitor Design Targeting the LasR Quorum Sensing Receptor of <i>Pseudomonas aeruginosa</i>. [PDF]
Khan A +7 more
europepmc +1 more source
Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access
Transplant Infectious Disease, EarlyView.
Jian Mei Li +2 more
wiley +1 more source
Design and Synthesis of Novel Chalcogen-1,2,4-triazoles as Lead-like Glutathione Peroxidase-Mimetic Antioxidants. [PDF]
Santos NLB +5 more
europepmc +1 more source
Triphenylphosphonium-triazole hybrids as mitochondria-targeted anticancer agents: design, DNA binding, cytotoxicity study, fluorescent apoptosis imaging and molecular docking. [PDF]
Güngör Ö +4 more
europepmc +1 more source
Phytotoxity of 3-amino-1, 2, 4-triazole for mulberry plants
openaire +1 more source

